Ascletis Pharma Inc.

Investors

Next Day Disclosure Returns - Share Buyback
2020-10-14
Next Day Disclosure Returns - Share Buyback
2020-10-12
Voluntary Announcement - Gannex Received U.S. IND Approval for Its NASH Drug Candidate ASC42, an FXR Agonist
2020-10-12
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2020
2020-09-30
2020 Interim Report
2020-09-24
Voluntary Announcement - Gannex Filed IND in the U.S. for Its NASH Drug Candidate ASC42, an FXR Agonist
2020-09-14
Voluntary Announcement - Gannex and Galmed Expand Development Programs for NASH through Research Collaboration of Aramchol and ASC41 (THR-beta Agonist)
2020-09-09
Voluntary Announcement - Proposed Share Repurchase under the Repurchase Mandate
2020-09-08
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2020
2020-09-04
2020 Interim Results
2020-08-28

3

© 2018 Ascletis Pharma Inc. All Rights Reserved
浙公网安备 33010802003344号浙ICP备11050387号-1